AU3667297A - Therapy for combined hyperlipidemia - Google Patents

Therapy for combined hyperlipidemia

Info

Publication number
AU3667297A
AU3667297A AU36672/97A AU3667297A AU3667297A AU 3667297 A AU3667297 A AU 3667297A AU 36672/97 A AU36672/97 A AU 36672/97A AU 3667297 A AU3667297 A AU 3667297A AU 3667297 A AU3667297 A AU 3667297A
Authority
AU
Australia
Prior art keywords
therapy
combined hyperlipidemia
hyperlipidemia
combined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36672/97A
Inventor
Michael R. Melino
Yale B Mitchel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9617898.3A external-priority patent/GB9617898D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU3667297A publication Critical patent/AU3667297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
AU36672/97A 1996-07-09 1997-07-03 Therapy for combined hyperlipidemia Abandoned AU3667297A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US2142096P 1996-07-09 1996-07-09
US60021420 1996-07-09
GBGB9617898.3A GB9617898D0 (en) 1996-08-28 1996-08-28 Method for treating homozygous familial hypercholesterolemia
GB9617898 1996-08-28
US2935196P 1996-10-31 1996-10-31
US60029351 1996-10-31
PCT/US1997/012426 WO1998001116A1 (en) 1996-07-09 1997-07-03 Therapy for combined hyperlipidemia

Publications (1)

Publication Number Publication Date
AU3667297A true AU3667297A (en) 1998-02-02

Family

ID=27268450

Family Applications (3)

Application Number Title Priority Date Filing Date
AU36672/97A Abandoned AU3667297A (en) 1996-07-09 1997-07-03 Therapy for combined hyperlipidemia
AU42289/97A Abandoned AU4228997A (en) 1996-07-09 1997-07-03 Method for treating homozygous familial hypercholesterolemia
AU43261/97A Abandoned AU4326197A (en) 1996-07-09 1997-07-03 Pharmaceutical compositions

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU42289/97A Abandoned AU4228997A (en) 1996-07-09 1997-07-03 Method for treating homozygous familial hypercholesterolemia
AU43261/97A Abandoned AU4326197A (en) 1996-07-09 1997-07-03 Pharmaceutical compositions

Country Status (2)

Country Link
AU (3) AU3667297A (en)
WO (3) WO1998001100A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030212996A1 (en) * 1996-02-08 2003-11-13 Wolzien Thomas R. System for interconnection of audio program data transmitted by radio to remote vehicle or individual with GPS location
IL141953A0 (en) * 1998-09-30 2002-03-10 Warner Lambert Co Method for preventing or delaying catheter-based revascularization
KR100590342B1 (en) 2001-03-28 2006-06-15 쉐링 코포레이션 Enantioselective synthesis of azetidinone intermediate compounds
AU2002358468A1 (en) * 2001-12-21 2003-07-15 Rigshospitalet Igamete recruitment and developmental competence in mammals by inhibiting the de novo sterol biosynthesis and/or promoting sterol efflux
AR040588A1 (en) 2002-07-26 2005-04-13 Schering Corp PHARMACEUTICAL FORMULATION INCLUDING AN INHIBITOR OF CHOLESTEROL ABSORPTION AND AN INHIBITOR OF A HMGCO TO REDUCTASE
JOP20080381B1 (en) 2007-08-23 2023-03-28 Amgen Inc Antigen Binding Proteins to Proprotein Convertase subtillisin Kexin type 9 (pcsk9)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806564A (en) * 1987-05-26 1989-02-21 Merck & Co., Inc. Antihypercholesterolemic beta-lactones
US4997849A (en) * 1989-06-23 1991-03-05 Merck & Co., Inc. Microbial transformation of simvastatin
US5393893A (en) * 1993-11-08 1995-02-28 Apotex, Inc. Process for producing simvastatin and analogs thereof

Also Published As

Publication number Publication date
AU4326197A (en) 1998-02-02
WO1998001119A2 (en) 1998-01-15
AU4228997A (en) 1998-02-02
WO1998001100A2 (en) 1998-01-15
WO1998001100A3 (en) 1998-02-12
WO1998001116A1 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
AUPO203996A0 (en) Therapeutic uses
AUPO665397A0 (en) Novel therapy for constipation
EP0796628A3 (en) Inhaler
AU2263197A (en) Diabetes therapy
AU2805195A (en) Therapeutic compounds
AU6276996A (en) Warming compounds
AU4925697A (en) Compounds
AU5252598A (en) Multi-trauma therapeutic machine
AUPO434196A0 (en) An improved therapeutic
AU4330097A (en) Pharmaceutical compounds
AU3667297A (en) Therapy for combined hyperlipidemia
AU4169897A (en) Pharmaceutical compounds
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AU5330198A (en) Therapeutic compounds
AU4502797A (en) Immunological therapy for cancer
AUPN770496A0 (en) Therapeutic compounds
AUPN770396A0 (en) Therapeutic compounds
AUPN924896A0 (en) Therapeutic compounds
AU3978697A (en) Plasmin-depletion therapy
AUPN959896A0 (en) Novel therapy for constipation
AUPN897396A0 (en) Novel therapy for constipation
AU1547197A (en) Transformer
AUPO181796A0 (en) Therapeutic uses
AU4771096A (en) Treatment for hypercholesterolemia
AU2003200183A1 (en) Cholestrol-lowering Therapy